SEI Investments
GLUE icon

SEI Investments’s Monte Rosa Therapeutics GLUE Stock Holding History

SEI Investments’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
50,028
-27,653
-36% -$522K ﹤0.01% 2208
2026
Q1 		$1.28M Buy
77,681
+18,013
+30% +$344K ﹤0.01% 2230
2025
Q4 		$936K Buy
59,668
+43,262
+264% +$583K ﹤0.01% 2213
2025
Q3 		$122K Hold
16,406
– – ﹤0.01% 2694
2025
Q2 		$74K Sell
16,406
-935
-5% -$4.17K ﹤0.01% 2720
2025
Q1 		$80.5K Buy
17,341
+105
+0.6% +$644 ﹤0.01% 2635
2024
Q4 		$120K Buy
+17,236
New +$129K ﹤0.01% 2553

Other funds holding GLUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SEI Investments's GLUE Position: Q2 2026 in Review

SEI Investments reduced its Monte Rosa Therapeutics (GLUE) stake by 36% in Q2 2026, selling an estimated $522K and leaving 50,028 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2208.

SEI Investments first reported a position in GLUE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.28M in Q1 2026. 192 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • SEI Investments held 50,028 shares of Monte Rosa Therapeutics worth $1.21M as of Q2 2026.
  • SEI Investments sold 27,653 Monte Rosa Therapeutics shares in Q2 2026, an estimated $522K.
  • Monte Rosa Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2208 holding.
  • SEI Investments first reported a position in Monte Rosa Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SEI Investments's Monte Rosa Therapeutics position peaked at $1.28M in Q1 2026.
  • 192 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.